Symbiotec Pharmalab logo

Symbiotec Pharmalab IPO Review

Symbiotec Pharmalab IPO Pages

πŸ“

Detailed review coming soon

Our editorial team is preparing an in-depth analysis of Symbiotec Pharmalab IPO covering company financials, valuation, strengths, risks and apply-or-skip verdict. Below is the structured information we have confirmed so far.

Price / Issue Price
β‚Ή988
Lot Size
15
Type
Mainboard
Exchange
BSE, NSE
View official prospectus β†’
Already listed. Issued at β‚Ή988, listed at β‚Ή988 (+0.00%) on 31 Aug 2026.